• Aker BioMarine is set to merge into Aker Capital NewCo, an Aker-controlled vehicle, with completion expected after trading ends on Oct. 1, 2026.
• Deal terms value each Aker BioMarine share at 0.0706 Aker shares, cash consideration of NOK 21.
• Record date for consideration is Oct. 5, 2026; Aker shares due Oct. 6, 2026; cash payment due Oct. 7, 2026.
• Trading in Aker BioMarine shares, including entitlement to the merger consideration, is scheduled to end on Oct. 1, 2026.
• Fractional Aker share entitlements will be rounded down; proceeds from sold excess shares will be distributed to affected shareholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aker BioMarine ASA published the original content used to generate this news brief via NewsWeb, the disclosure sustem operated by Euronext Oslo (Ref. ID: 202609300100OSLOBORSNEWS__EN_2AC82B1E3ACB94A508D3BC347C1A74A), on September 30, 2026, and is solely responsible for the information contained therein.